Extracorporeal Shock Wave Treatment (ESWT) enhances the  in vitro -induced differentiation of human tendon-derived stem/progenitor cells (hTSPCs)

Laura Leone; Salvatore Raffa; Mario Vetrano; Danilo Ranieri; Florence Malisan; Cristina Scrofani; Maria Chiara Vulpiani; Andrea Ferretti; Maria Rosaria Torrisi; Vincenzo Visco

doi:10.18632/oncotarget.7064

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers: Pathology:

Extracorporeal Shock Wave Treatment (ESWT) enhances the in vitro-induced differentiation of human tendon-derived stem/progenitor cells (hTSPCs)

Laura Leone, Salvatore Raffa, Mario Vetrano, Danilo Ranieri, Florence Malisan, Cristina Scrofani, Maria Chiara Vulpiani, Andrea Ferretti, Maria Rosaria Torrisi and Vincenzo Visco _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:6410-6423. https://doi.org/10.18632/oncotarget.7064

Metrics: PDF 2549 views | HTML 2592 views | ?

Abstract

Laura Leone1, Salvatore Raffa1,4, Mario Vetrano2, Danilo Ranieri1, Florence Malisan3, Cristina Scrofani1, Maria Chiara Vulpiani2, Andrea Ferretti2, Maria Rosaria Torrisi1,4 and Vincenzo Visco1,4

1 Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, “Sapienza” University of Rome, Rome, Italy

2 Department of Orthopedics and Traumatology, Sant’Andrea Hospital, Faculty of Medicine and Psychology, “Sapienza” University of Rome, Rome, Italy

3 Department of Biomedicine and Prevention, Laboratory of Signal Transduction, “Tor Vergata” University of Rome, Rome, Italy

4 Cellular Diagnostics Unit, Sant’Andrea Hospital, Rome, Italy

Correspondence to:

Vincenzo Visco, email:

Keywords: differentiation, tendon, stem cells, healing, ESWT, Pathology Section

Received: August 03, 2015 Accepted: January 13, 2016 Published: January 28, 2016

Abstract

Extracorporeal shock wave therapy (ESWT) is a non-invasive and innovative technology for the management of specific tendinopathies. In order to elucidate the ESWT-mediated clinical benefits, human Tendon-derived Stem/Progenitor cells (hTSPCs) explanted from 5 healthy semitendinosus (ST) and 5 ruptured Achilles (AT) tendons were established. While hTSPCs from the two groups showed similar proliferation rates and stem cell surface marker profiles, we found that the clonogenic potential was maintained only in cells derived from healthy donors. Interestingly, ESWT significantly accelerated hTSPCs differentiation, suggesting that the clinical benefits of ESWT may be ascribed to increased efficiency of tendon repair after injury.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7064

Publication Alerts

Research Papers: Pathology:

Extracorporeal Shock Wave Treatment (ESWT) enhances the in vitro-induced differentiation of human tendon-derived stem/progenitor cells (hTSPCs)

Abstract